PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-19.78%
Both yoy net incomes decline, with MRVL at -215.79%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
5.31%
D&A growth well above MRVL's 1.98%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-41.41%
Negative yoy deferred tax while MRVL stands at 97.44%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-13.92%
Both cut yoy SBC, with MRVL at -10.54%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
4766.67%
Slight usage while MRVL is negative at -965.08%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
1045.00%
AR growth well above MRVL's 295.28%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
49.16%
Some inventory rise while MRVL is negative at -117.58%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-137.04%
Both negative yoy AP, with MRVL at -42.59%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
15.66%
Some yoy usage while MRVL is negative at -185.43%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
112.12%
Some yoy increase while MRVL is negative at -49.66%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-0.67%
Both yoy CFO lines are negative, with MRVL at -14.48%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
23.21%
Some CapEx rise while MRVL is negative at -17.65%. John Neff would see competitor possibly building capacity while we hold back expansions.
-400.00%
Both yoy lines negative, with MRVL at -111.36%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
16.72%
Purchases growth of 16.72% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
18.23%
Liquidation growth of 18.23% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-20.00%
We reduce yoy other investing while MRVL is 122.92%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
81.64%
We have mild expansions while MRVL is negative at -23.70%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-33.82%
Negative yoy issuance while MRVL is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-41.30%
We cut yoy buybacks while MRVL is 47.20%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.